The U.S. will purchase 2 million doses of a groundbreaking twice-yearly HIV prevention shot for distribution in low-income countries by 2028. The drug lenacapvir nearly eliminated new infections in ...
A vial of lenacapavir, the new HIV prevention injectable drug that only needs to be administered twice yearly but provides almost complete protection. (Nardus Engelbrecht | AP) The U.S. announced ...
The Choose U World AIDS Day panel brought together three longtime advocates living with HIV to talk about care, stigma, and what living with HIV over the long-term means to them. The conversation ...
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, to the African nations of Eswatini and Zambia, the U.S. State Department ...
The U.S. announced Thursday that it will make an investment in the new HIV prevention drug called lenacapavir that's been hailed as a "breakthrough" and a "game changer" by the medical community. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results